Skip to main content

USANA HEALTH SCIENCES INC

For the period ended Mar 29, 2025. Filed May 6, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 29, 2025 · Filed May 6, 2025

USNA$13.10-5.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Comprehensive Income

Three Months Ended
March 29,2025March 30,2024
Net sales$249,539$227,800
Cost of sales52,44543,069
Gross profit197,094184,731
Operating expenses:
Associate incentives89,98595,758
Selling, general and administrative91,43864,300
Total operating expenses181,423160,058
Earnings from operations15,67124,673
Other income (expense):
Interest income7232,676
Interest expense(411)(52)
Other, net756(186)
Other income (expense), net1,0682,438
Earnings before income taxes16,73927,111
Income taxes7,44910,574
Net earnings9,29016,537
Less: Net earnings (loss) attributable to redeemable noncontrolling interest(112)—
Net earnings attributable to USANA$9,402$16,537
Earnings per common share attributable to USANA
Basic$0.49$0.86
Diluted$0.49$0.86
Weighted average common shares outstanding
Basic19,04919,174
Diluted19,08519,302
Comprehensive income:
Net earnings$9,290$16,537
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment125(5,102)
Tax benefit (expense) related to foreign currency translation adjustment(207)204
Other comprehensive income (loss), net of tax(82)(4,898)
Comprehensive income9,20811,639
Less: comprehensive income (loss) attributable to redeemable noncontrolling interest(112)—
Comprehensive income attributable to USANA$9,320$11,639
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.